NASDAQ:XBIT - XBiotech Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$4.25 -0.08 (-1.85 %)
(As of 06/24/2018 10:21 AM ET)
Previous Close$4.25
Today's Range$4.00 - $4.44
52-Week Range$3.55 - $5.80
Volume2.15 million shs
Average Volume43,262 shs
Market Capitalization$153.80 million
P/E RatioN/A
Dividend YieldN/A
Beta0.68
XBiotech logoXBiotech Inc., a pre-market biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company's lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer. It has also investigating its lead product candidate in various clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum, and hidradenitis suppurativa, as well as staphylococcus aureus infection, influenza, and clostridium difficile infection diseases. XBiotech, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Receive XBIT News and Ratings via Email

Sign-up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:XBIT
CUSIPN/A
Phone512-386-2900

Debt

Debt-to-Equity RatioN/A
Current Ratio12.24
Quick Ratio12.24

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.70 per share
Price / Book2.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-33,150,000.00
Net MarginsN/A
Return on Equity-41.50%
Return on Assets-39.43%

Miscellaneous

Employees51
Outstanding Shares35,520,000

The Truth About Cryptocurrencies

XBiotech (NASDAQ:XBIT) Frequently Asked Questions

What is XBiotech's stock symbol?

XBiotech trades on the NASDAQ under the ticker symbol "XBIT."

How were XBiotech's earnings last quarter?

XBiotech Inc (NASDAQ:XBIT) posted its quarterly earnings data on Monday, November, 14th. The biopharmaceutical company reported ($0.38) earnings per share for the quarter, topping analysts' consensus estimates of ($0.46) by $0.08. View XBiotech's Earnings History.

When is XBiotech's next earnings date?

XBiotech is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for XBiotech.

Who are some of XBiotech's key competitors?

Who are XBiotech's key executives?

XBiotech's management team includes the folowing people:
  • Mr. John Simard, Founder, Pres, CEO & Chairman (Age 56)
  • Ms. Queena Han, VP of Fin. & HR and Sec. (Age 51)
  • Mr. Benjamín Guzmán, Sr. VP of Corp. Strategy & Fin. (Age 62)
  • Dr. Sushma Shivaswamy Ph.D., Chief Scientific Officer (Age 40)
  • Mr. Trey Benson, Commercial Head

When did XBiotech IPO?

(XBIT) raised $76 million in an IPO on Wednesday, April 15th 2015. The company issued 4,000,000 shares at a price of $18.00-$20.00 per share. WR Hambrecht + Co acted as the underwriter for the IPO.

Has XBiotech been receiving favorable news coverage?

Media coverage about XBIT stock has been trending somewhat positive this week, Accern reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. XBiotech earned a coverage optimism score of 0.08 on Accern's scale. They also gave headlines about the biopharmaceutical company an impact score of 44.63 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are XBiotech's major shareholders?

XBiotech's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (0.11%). View Institutional Ownership Trends for XBiotech.

Which institutional investors are buying XBiotech stock?

XBIT stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. View Insider Buying and Selling for XBiotech.

How do I buy shares of XBiotech?

Shares of XBIT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is XBiotech's stock price today?

One share of XBIT stock can currently be purchased for approximately $4.25.

How big of a company is XBiotech?

XBiotech has a market capitalization of $153.80 million. XBiotech employs 51 workers across the globe.

How can I contact XBiotech?

XBiotech's mailing address is 8201 E. RIVERSIDE DRIVE BUILDING 4 SUITE 100, AUSTIN TX, 78744. The biopharmaceutical company can be reached via phone at 512-386-2900 or via email at [email protected]


MarketBeat Community Rating for XBiotech (XBIT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  217
MarketBeat's community ratings are surveys of what our community members think about XBiotech and other stocks. Vote "Outperform" if you believe XBIT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XBIT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.